90Y-epratuzumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 90Y-epratuzumab, covering 2017-01-19 to 2017-01-19. Get the full timeline:
Most recent: Clinical Trial Update: Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia [Phase 1, Phase 2]